Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Cann Group ( (AU:CAN) ) just unveiled an update.
Cann Group Limited has announced the quotation of 127,597,050 ordinary fully paid securities on the Australian Securities Exchange (ASX) as of November 24, 2025. This move is part of previously announced transactions and is expected to enhance the company’s market presence and liquidity, potentially benefiting stakeholders by improving access to capital and increasing shareholder value.
More about Cann Group
Cann Group Limited operates in the pharmaceutical industry, focusing on the cultivation and production of medicinal cannabis products. The company is primarily engaged in developing cannabis-based therapies and products for medical use, targeting both domestic and international markets.
YTD Price Performance: -71.79%
Average Trading Volume: 3,758,511
Technical Sentiment Signal: Sell
Current Market Cap: A$9.13M
Find detailed analytics on CAN stock on TipRanks’ Stock Analysis page.